Dr Martin Hall is the Head of Life Sciences at Hardman & Co.
Martin’s career in the City started as a healthcare analyst in 1987, working at Morgan Grenfell and then UBS. He joined HSBC in 1992, where he was Head of Global Pharmaceutical/Healthcare Equity Research. In 2005, he set up as a Life Sciences Analyst and Corporate Broker under the umbrella of Eden Financial Limited. After two years of a post-doctoral Royal Society Fellowship at the Collège de France, Paris, he became leader in Biochemical Pharmacology at the Parke-Davis Research Centre in Cambridge. Martin is a member of Royal Pharmaceutical Society.
Martin joined Hardman & Co in June 2013. He holds a B.Pharm in Pharmacy from the School of Pharmacy, University of London, and has a PhD in Neuropharmacology from the University of London.
